Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme?

被引：9

作者：

Goeteyn, V

Naeyaert, JM

Lambert, J

Monbaliu, L

Vermander, F

机构：

[1] State Univ Ghent Hosp, Dept Dermatol, B-9000 Ghent, Belgium

[2] Univ Antwerp Hosp, Dept Dermatol, Antwerp, Belgium

[3] OLV Ter Linden Knokke Heist, Knokke Heist, Belgium

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2000年 / 142卷 / 03期

关键词：

D O I：

10.1046/j.1365-2133.2000.03391.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

引用

页码：578 / 579

页数：2

共 11 条

[1]

BARBAUD, 1997, AUSTRALAS J DERMATOL, V20, P247

[2]

Brooke R, 1998, BRIT J DERMATOL, V139, P1132, DOI 10.1046/j.1365-2133.1998.2576q.x

[3]

CARSTENS J, 1994, ACTA DERM-VENEREOL, V74, P391

[4]

Gupta AK, 1998, BRIT J DERMATOL, V138, P529, DOI 10.1046/j.1365-2133.1998.02140.x

[5]

Safety of oral terbinafine - Results of a postmarketing surveillance study in 25884 patients [J].

Hall, M ;

Monka, C ;

Krupp, P ;

OSullivan, D .

ARCHIVES OF DERMATOLOGY, 1997, 133 (10) :1213-1219

[6]

Holmes S, 1998, BRIT J DERMATOL, V139, P1133, DOI 10.1046/j.1365-2133.1998.2576r.x

[7]

MCGREGOR JM, 1994, BRIT J DERMATOL, V131, P578

[8]

Murphy M, 1998, BRIT J DERMATOL, V138, P708, DOI 10.1046/j.1365-2133.1998.02194.x

[9]

STEVENS-JOHNSON SYNDROME AFTER TERBINAFINE THERAPY [J].

RZANY, B ;

MOCKENHAUPT, M ;

GEHRING, W ;

SCHOPF, E .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (03) :509-509

[10]

ORAL TERBINAFINE AND ERYTHEMA MULTIFORME [J].

TODD, P ;

HALPERN, S ;

MUNRO, DD .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (03) :247-248

← 1 2 →